JPMorgan cuts Rocket Pharmaceuticals stock rating to neutral

Related
Lantern pharma investors see $168,418 in stock sales
2 hours ago
1
Australia retail sales dip 0.1% in April, miss forecasts
2 hours ago
1
RIGHT SIDEBAR TOP AD
Trending
Popular
What we know about the New York City helicopter crash that k...
1 month ago
193
Stanford 2025 AI Index Reveals Surge in Adoption, Investment...
1 month ago
144
Western Governors University Joins Open edX as a Mission-Ali...
2 months ago
131
Microsoft Adds New Agentic AI Tools to Security Copilot
1 month ago
127
Paxton's challenge isn't the only one worrying Senate Republ...
1 month ago
123
RIGHT SIDEBAR BOTTOM AD
© Powerbits - breaking news today 2025. All rights are reserved